Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin
- PMID: 26327197
- DOI: 10.1111/jpi.12269
Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin
Abstract
Diabetes mellitus (DM) increases myocardial oxidative stress and endoplasmic reticulum (ER) stress. Melatonin confers cardioprotective effect by suppressing oxidative damage. However, the effect and mechanism of melatonin on myocardial ischemia-reperfusion (MI/R) injury in type 2 diabetic state are still unknown. In this study, we developed high-fat diet-fed streptozotocin (HFD-STZ) rat, a well-known type 2 diabetic model, to evaluate the effect of melatonin on MI/R injury with a focus on silent information regulator 1 (SIRT1) signaling, oxidative stress, and PERK/eIF2α/ATF4-mediated ER stress. HFD-STZ treated rats were exposed to melatonin treatment in the presence or the absence of sirtinol (a SIRT1 inhibitor) and subjected to MI/R surgery. Compared with nondiabetic animals, type 2 diabetic rats exhibited significantly decreased myocardial SIRT1 signaling, increased apoptosis, enhanced oxidative stress, and ER stress. Additionally, further reduced SIRT1 signaling, aggravated oxidative damage, and ER stress were found in diabetic animals subjected to MI/R surgery. Melatonin markedly reduced MI/R injury by improving cardiac functional recovery and decreasing myocardial apoptosis in type 2 diabetic animals. Melatonin treatment up-regulated SIRT1 expression, reduced oxidative damage, and suppressed PERK/eIF2α/ATF4 signaling. However, these effects were all attenuated by SIRT1 inhibition. Melatonin also protected high glucose/high fat cultured H9C2 cardiomyocytes against simulated ischemia-reperfusion injury-induced ER stress by activating SIRT1 signaling while SIRT1 siRNA blunted this action. Taken together, our study demonstrates that reduced cardiac SIRT1 signaling in type 2 diabetic state aggravates MI/R injury. Melatonin ameliorates reperfusion-induced oxidative stress and ER stress via activation of SIRT1 signaling, thus reducing MI/R damage and improving cardiac function.
Keywords: endoplasmic reticulum stress; melatonin; myocardial ischemia-reperfusion; oxidative stress; silent information regulator 1 signaling; type 2 diabetes mellitus.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway.Oxid Med Cell Longev. 2018 Feb 20;2018:3159801. doi: 10.1155/2018/3159801. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29675132 Free PMC article.
-
Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation.Apoptosis. 2017 Jul;22(7):942-954. doi: 10.1007/s10495-017-1378-y. Apoptosis. 2017. PMID: 28455824
-
Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1.J Pineal Res. 2014 Sep;57(2):228-38. doi: 10.1111/jpi.12161. Epub 2014 Aug 13. J Pineal Res. 2014. PMID: 25052362
-
Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.Oxid Med Cell Longev. 2017;2017:6437467. doi: 10.1155/2017/6437467. Epub 2017 Feb 19. Oxid Med Cell Longev. 2017. PMID: 28298952 Free PMC article. Review.
-
SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion.Pharmacol Res. 2024 Jan;199:106957. doi: 10.1016/j.phrs.2023.106957. Epub 2023 Oct 10. Pharmacol Res. 2024. PMID: 37820856 Review.
Cited by
-
Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway.Oxid Med Cell Longev. 2018 Feb 20;2018:3159801. doi: 10.1155/2018/3159801. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29675132 Free PMC article.
-
Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.Naunyn Schmiedebergs Arch Pharmacol. 2020 Apr;393(4):521-536. doi: 10.1007/s00210-020-01822-4. Epub 2020 Jan 30. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32002576 Review.
-
Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway.Oxid Med Cell Longev. 2021 May 27;2021:8882130. doi: 10.1155/2021/8882130. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34336116 Free PMC article.
-
Melatonin: does it have utility in the treatment of haematological neoplasms?Br J Pharmacol. 2018 Aug;175(16):3251-3262. doi: 10.1111/bph.13966. Epub 2017 Sep 9. Br J Pharmacol. 2018. PMID: 28880375 Free PMC article. Review.
-
Bioinspired drug-delivery system emulating the natural bone healing cascade for diabetic periodontal bone regeneration.Bioact Mater. 2022 Sep 14;21:324-339. doi: 10.1016/j.bioactmat.2022.08.029. eCollection 2023 Mar. Bioact Mater. 2022. PMID: 36185747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources